Pzena Investment Management LLC Increases Stock Position in USANA Health Sciences, Inc. (NYSE:USNA)

Pzena Investment Management LLC raised its holdings in USANA Health Sciences, Inc. (NYSE:USNA) by 3.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,087,076 shares of the company’s stock after purchasing an additional 37,466 shares during the quarter. Pzena Investment Management LLC owned 5.70% of USANA Health Sciences worth $39,015,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently added to or reduced their stakes in the business. Pacer Advisors Inc. boosted its holdings in USANA Health Sciences by 8.8% in the 4th quarter. Pacer Advisors Inc. now owns 592,001 shares of the company’s stock valued at $21,247,000 after purchasing an additional 47,745 shares in the last quarter. State Street Corp boosted its stake in shares of USANA Health Sciences by 0.6% during the 3rd quarter. State Street Corp now owns 435,164 shares of the company’s stock worth $16,501,000 after acquiring an additional 2,782 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of USANA Health Sciences by 4.5% during the 3rd quarter. Geode Capital Management LLC now owns 297,120 shares of the company’s stock worth $11,269,000 after acquiring an additional 12,898 shares in the last quarter. Principal Financial Group Inc. boosted its stake in shares of USANA Health Sciences by 2.8% during the 4th quarter. Principal Financial Group Inc. now owns 53,603 shares of the company’s stock worth $1,924,000 after acquiring an additional 1,480 shares in the last quarter. Finally, Nordea Investment Management AB boosted its stake in shares of USANA Health Sciences by 5.7% during the 4th quarter. Nordea Investment Management AB now owns 50,450 shares of the company’s stock worth $1,814,000 after acquiring an additional 2,723 shares in the last quarter. Hedge funds and other institutional investors own 54.25% of the company’s stock.

USANA Health Sciences Price Performance

Shares of USANA Health Sciences stock opened at $33.18 on Tuesday. USANA Health Sciences, Inc. has a 1 year low of $27.71 and a 1 year high of $50.32. The company has a market capitalization of $632.47 million, a P/E ratio of 11.73, a P/E/G ratio of 0.93 and a beta of 0.98. The business has a 50 day moving average price of $32.96 and a 200 day moving average price of $36.18.

USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings data on Tuesday, February 25th. The company reported $0.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.49 by $0.15. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. The firm had revenue of $213.61 million during the quarter, compared to the consensus estimate of $208.82 million. As a group, research analysts expect that USANA Health Sciences, Inc. will post 2.45 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on USNA shares. StockNews.com lowered USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 14th. DA Davidson decreased their price target on USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating on the stock in a research note on Thursday, February 27th. Finally, Sidoti lowered USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, February 18th.

Insider Buying and Selling

In other USANA Health Sciences news, CEO Jim Brown sold 5,000 shares of the business’s stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $29.47, for a total value of $147,350.00. Following the completion of the transaction, the chief executive officer now directly owns 15,716 shares in the company, valued at approximately $463,150.52. The trade was a 24.14 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders sold 6,454 shares of company stock worth $190,459 in the last ninety days. Insiders own 0.33% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.